Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16
Closed -$463 1794
2025
Q1
$463 Hold
16
﹤0.01% 2130
2024
Q4
$693 Buy
+16
New +$755 ﹤0.01% 2069
2024
Q2
Sell
-1,030
Closed -$45.8K 1942
2024
Q1
$45.8K Sell
1,030
-417
-29% -$20K ﹤0.01% 1849
2023
Q4
$66.6K Buy
+1,447
New +$64.5K ﹤0.01% 1850
2023
Q3
Sell
-100
Closed -$3.86K 2020
2023
Q2
$3.86K Hold
100
﹤0.01% 2010
2023
Q1
$3.78K Hold
100
﹤0.01% 2023
2022
Q4
$3.43K Sell
100
-1,970
-95% -$59K ﹤0.01% 1865
2022
Q3
$60K Buy
2,070
+1,970
+1,970% +$60K ﹤0.01% 1638
2022
Q2
$3K Hold
100
﹤0.01% 1645
2022
Q1
$5K Buy
+100
New +$5.14K ﹤0.01% 1626

Other funds holding DCBO

Amundi's DCBO Position: Q2 2025 in Review

Amundi sold out of Docebo (DCBO) in Q2 2025, closing a stake of 16 shares — an estimated $463 sold.

Amundi first reported a position in DCBO in Q1 2022 and held it in 10 quarters. The position peaked at $66.6K in Q4 2023. 91 funds tracked by Wall St. Rank hold DCBO as of Q2 2025.

  • Amundi reported no remaining Docebo position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 16 Docebo shares in Q2 2025, an estimated $463.
  • Amundi first reported a position in Docebo in Q1 2022 and held it in 10 quarters.
  • Amundi's Docebo position peaked at $66.6K in Q4 2023.
  • 91 funds tracked by Wall St. Rank held Docebo as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.